Ardent Health Partners, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NYSE
Ardent Health reported a decrease in total revenue for the three months ended June 30, 2026, driven by lower net patient service revenue per adjusted admission, while operating expenses increased significantly.
NYSE
Ardent Health reports a 7.0% increase in total revenue for Q1 2026, driven by higher net patient service revenue per adjusted admission, despite a slight dip in overall admissions.
NYSE
Ardent Health, Inc. reported a net loss of $23.48 million for Q3 2025, impacted by a $42.6 million revenue accounting estimate change and a $47.2 million increase in professional liability reserves.
NYSE
Ardent Health, Inc. announced robust financial results for the second quarter and first half of 2025, driven by increased patient volumes and higher reimbursement rates, despite new regulatory challenges.
NYSE
Ardent Health Partners' Q1 2025 revenue increased by 4% year-over-year, driven by a rise in adjusted admissions and net patient service revenue per adjusted admission.
NYSE
Ardent Health Partners saw a 5.2% increase in total revenue for the third quarter of 2024, driven by higher admissions and net patient service revenue.
NYSE
Ardent Health Partners saw a 7.5% increase in total revenue for the second quarter of 2024, driven by both higher patient volumes and improved revenue per adjusted admission.